#Spain #Barcelona #Biopharma #Bayer AG #Veeva Link

Leading Biopharma Companies Embrace Veeva Link Key People

In an impressive move towards modernization and efficiency, Veeva Systems recently revealed that 13 of the world’s top 20 biopharmaceutical companies have standardized their approaches using Veeva Link Key People. This strategic adoption is set to enhance customer engagement efforts while providing critical datasets that support artificial intelligence (AI) initiatives on a global scale.

A Game Changer in Customer Engagement

This adoption marks a significant trend among biopharmaceutical firms of all sizes, with 38 new customers acquiring access to Link Key People in the last year alone, showcasing a growing confidence in Veeva’s capabilities. Notably, three of these top firms have made Veeva Link their international standard, illustrating a shift in how these companies intend to interact with healthcare providers (HCPs).

Dr. Daniel Jardanhazi-Kurutz, Deputy Director for Customer Engagement at Bayer AG, highlighted the improved decision-making powers afforded by access to Veeva Link Key People data. He stated that it not only enhances targeting precision but also fosters more engaging interactions with healthcare professionals, leading ultimately to better health outcomes for patients. According to him, the data has become an integral facet of Bayer’s operational framework, thus amplifying the efficacy of their AI-driven platforms.

Trust, Data, and Innovations

One of the standout features of Veeva Link Key People is its ability to deliver reliable insights that serve both medical and commercial teams effectively. Furthermore, analytics departments are leveraging the same data to refine their AI models, a critical step towards optimizing business strategies. New innovations such as AI-powered summaries, tailor-made notifications, and expanding digital data sources are enhancing customer interactions and revealing new opportunities for engagement.

The Link Direct Data API is another noteworthy addition, offering data teams unprecedented high-speed access to helpful resources, thus tightening the operational efficiency across various departments.

David Medina Tato, Vice President of Strategy for Link Key People at Veeva, emphasized how trusted customer insights form the backbone of AI advancement and underscore the importance of successful launches. The growing number of biopharma companies and emerging biotech firms utilizing Link Key People indicates a bright future for substantial industry-wide improvements in engagement, fortified by comprehensive KOL data.

Connection Through Veeva Data Cloud

Veeva Link Key People is part of a more extensive suite called Veeva Data Cloud, which also includes Veeva OpenData, Veeva HCP 360, and Veeva Compass. This suite integrates Veeva's Common Data Architecture, enabling seamless connections between data and software, thereby enhancing collaborative efforts across the board.

About Veeva Systems

Veeva Systems stands out as a leader in providing cloud solutions tailored for the life sciences sector. The company's commitment to innovation and excellence enables it to serve over 1,500 customers, ranging from expansive biopharmaceutical companies to dynamic, emerging biotechs. As a Public Benefit Corporation, Veeva is dedicated to considering the interests of all stakeholders, ensuring that their services and products uphold high standards of quality and reliability. For more in-depth insights, visit their official website at veeva.com/eu.

Conclusion

As more biopharmaceutical companies embrace digital transformation through tools like Veeva Link Key People, the landscape of customer engagement continues to evolve. These advancements not only enhance business operations but ultimately contribute to improved patient healthcare outcomes – a goal shared by all in the industry. The combination of reliable data, innovative technology, and a focus on stakeholder success will undoubtedly pave the way for future growth in the biopharma sector.